Literature DB >> 27882996

CRISPR gene-editing tested in a person for the first time.

David Cyranoski.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27882996     DOI： 10.1038/nature.2016.20988

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  109 in total

1.  Fluorescent labeling of CRISPR/Cas9 RNP for gene knockout in HSPCs and iPSCs reveals an essential role for GADD45b in stress response.

Authors:  Masoud Nasri; Perihan Mir; Benjamin Dannenmann; Diana Amend; Tessa Skroblyn; Yun Xu; Klaus Schulze-Osthoff; Maksim Klimiankou; Karl Welte; Julia Skokowa
Journal:  Blood Adv       Date:  2019-01-08

Review 2.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

3.  A Universal GSH-Responsive Nanoplatform for the Delivery of DNA, mRNA, and Cas9/sgRNA Ribonucleoprotein.

Authors:  Guojun Chen; Ben Ma; Yuyuan Wang; Shaoqin Gong
Journal:  ACS Appl Mater Interfaces       Date:  2018-05-25       Impact factor: 9.229

4.  Unlocking the epigenetic code of T cell exhaustion.

Authors:  Jiazhu Wu; Huidong Shi
Journal:  Transl Cancer Res       Date:  2017-03       Impact factor: 1.241

5.  Attitudes of clinical geneticists and certified genetic counselors to genome editing and its clinical applications: A nation-wide questionnaire survey in Japan.

Authors:  Iku Taguchi; Takahiro Yamada; Rina Akaishi; Issei Imoto; Kenji Kurosawa; Kaname Nakatani; Fumio Nomura; Haruka Hamanoue; Maki Hyodo; Hiromi Murakami; Hiroshi Yoshihashi; Junko Yotsumoto; Shinji Kosugi
Journal:  J Hum Genet       Date:  2019-07-05       Impact factor: 3.172

Review 6.  [CRISPR-Cas system as molecular scissors for gene therapy].

Authors:  G A Heinz; M-F Mashreghi
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

Review 7.  CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials.

Authors:  Leonhard Kick; Marion Kirchner; Sabine Schneider
Journal:  Bioengineered       Date:  2017-03-13       Impact factor: 3.269

8.  Why Gene Editors Like CRISPR/Cas May Be a Game-Changer for Neuroweapons.

Authors:  Diane DiEuliis; James Giordano
Journal:  Health Secur       Date:  2017-06-02

9.  Genome editing to 're-write' wrongs.

Authors:  Mary Ellen Perry; Kayla M Valdes; Elizabeth Wilder; Christopher P Austin; Philip J Brooks
Journal:  Nat Rev Drug Discov       Date:  2018-06-22       Impact factor: 84.694

Review 10.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.